drugset
drugset / Trial / NCT03742791

Safety, Tolerability and Pharmacokinetics of 14-day Multiple Dose Titrations of TS-134 in Healthy Volunteers

NCT03742791 ↗

Phase 1 Completed 59 enrolled Taisho Pharmaceutical R&D Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a Phase 1 study involving multiple dose titrations of TS-134 in healthy male and female subjects. The safety, tolerability and pharmacokinetics of multiple dose titrations of TS-134 will be evaluated.

Timeline

Start
2016-06-28
Primary completion
2016-12-12
Completion
2016-12-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TS-134 Unknown 5 mg Oral
Subject TS-134 Unknown 80 mg Oral

Indications

No indication recorded.